On July 30, 2010, the PMPRB released its latest newsletter. The Newsletter, inter alia, provides a summary of its 2009 Annual Report, which was tabled before the Government on June 16, 2010, and a summary of the status of Board proceedings. It should be noted that a number of the outstanding Board proceedings involve generic patentees who have failed to file.

Additionally, of note is that the Board’s redetermination of certain issues ordered by the Federal Court late last year in the Copaxone case has been set down for October 4-5, 2010 (see our previous newsletter discussing this decision here) Further, it is noted that the Celegene case for which leave was accepted by the Supreme Court of Canada has been set down to be heard by the country’s top court on November 10, 2010 (see our previous newsletters discussing the trial decision here and court of appeal decision here.).

For more information, please see the PMPRB Newsletter:

http://www.pmprb-cepmb.gc.ca/english/View.asp?x=1346&mp=287